Cargando…
Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
BACKGROUND: Programmed cell death 4 (Pdcd4) is a novel tumour suppressor and originally identified as a neoplastic transformation inhibitor. The aim of this study was to investigate the expression, prognostic significance and potential function of Pdcd4 in ovarian cancer. RESULTS: The expression of...
Autores principales: | Wei, Na, Liu, Stephanie S, Leung, Thomas HY, Tam, Kar F, Liao, Xiao Y, Cheung, Annie NY, Chan, Karen KL, Ngan, Hextan YS |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745358/ https://www.ncbi.nlm.nih.gov/pubmed/19728867 http://dx.doi.org/10.1186/1476-4598-8-70 |
Ejemplares similares
-
Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
por: Wei, Na, et al.
Publicado: (2012) -
Down-regulation of Sox7 is associated with aberrant activation of Wnt/β-catenin signaling in endometrial cancer
por: Chan, David W, et al.
Publicado: (2012) -
Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers
por: Jiang, LiLi, et al.
Publicado: (2010) -
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis
por: Fassan, Matteo, et al.
Publicado: (2010) -
The role of tumour suppressor PDCD4 in beta cell death in hypoxia
por: Kumar, Sandeep, et al.
Publicado: (2017)